Skip to main content
. 2021 Oct 25;2021(10):CD012612. doi: 10.1002/14651858.CD012612.pub2

Hunter 2011b.

Study characteristics
Methods RCT
Randomised (independent, concealed) to 4 groups. 3 groups received different amounts of the intervention and the 4th was a control group. For this Cochrane Review, we excluded the control group
Stratified by clinical centre, severity of paresis, and spatial neglect
Participants 76 participants in 4 study groups. All participants were 8–84 days postevent
Group 2: n = 18; mean age 73.3 years; 61% male
Group 3: n = 19; mean age 72.9 years; 42% male
Group 4: n = 20; mean age 72.5 years; 45% male
Inpatient setting (or at home if discharged) in the UK
Interventions The intervention was MTS of the forearm and hand. This intervention had specific components that could be adapted to individual presentation
Group 2: up to 30 minutes a day of MTS
Group 3: up to 60 minutes a day of MTS
Group 4: up to 120 minutes a day of MTS
The intervention was provided every working day for 14 days
Outcomes Primary outcome: arm section of the Motricity Index
Secondary outcome: ARAT
Measurements were at baseline and end of intervention phase. Adverse events were monitored on each working day
Notes Hunter 2011b reports the following pair‐wise comparison: group 2 (n = 9) vs group 4 (n = 20)
Both the planned number of minutes and the actual number of minutes of therapy provided are recorded
Paper reported change scores, but authors kindly provided raw data, so mean and SD could be calculated 
Conflict of interest: no potential conflicts of interest with respect to the authorship or publication of this article
Funding:  the author(s) disclosed receipt of the following financial support for the research or authorship (or both) of the article. Quote: "We are grateful to The Stroke Association for the provision of funding for this study.  The Stroke Association had no role in the design, conduction, or interpretation of the results of this study."